| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/01/1994 | US5360788 Sodium pyrithione and polymyxin B sulfate mixture; dermatology; microbiocidal |
| 11/01/1994 | US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells |
| 11/01/1994 | US5360716 Human tumor necrosis factor αspecific monoclonal antibody and method for detecting human tumor necrosis factor α |
| 11/01/1994 | US5360611 Antiinflammatory |
| 11/01/1994 | US5360605 Preservation of blood, tissues and biological fluids |
| 11/01/1994 | CA1332808C Polyester-based composition for the controlled release of medicinal substances |
| 10/31/1994 | CA2122531A1 Anionic polymerization initiators and reduced hysteresis products therefrom |
| 10/30/1994 | CA2122429A1 Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis of treatment of arteriosclerosis |
| 10/30/1994 | CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors |
| 10/28/1994 | WO1993022370A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
| 10/28/1994 | CA2134346A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
| 10/27/1994 | WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 10/27/1994 | WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 10/27/1994 | WO1994024285A1 Macrophage inflammatory protein variants |
| 10/27/1994 | WO1994024284A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 10/27/1994 | WO1994024281A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 10/27/1994 | WO1994024279A2 Agents for the prevention and treatment of huntington's disease and other neurological disorders |
| 10/27/1994 | WO1994024278A1 Selecting genes encoding catalytic antibodies |
| 10/27/1994 | WO1994024276A1 Glutamylcysteine synthetase light subunit |
| 10/27/1994 | WO1994024275A1 Model for gonococcal infection |
| 10/27/1994 | WO1994024274A1 Isolation, selection and propagation of animal transgenic stem cells |
| 10/27/1994 | WO1994024273A1 Stable collagenase compositions and methods for their preparation |
| 10/27/1994 | WO1994024263A1 Needleless syringe using supersonic gas flow for particle delivery |
| 10/27/1994 | WO1994024168A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
| 10/27/1994 | WO1994024167A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 10/27/1994 | WO1994024166A1 Unique sperm antigens and methods of use |
| 10/27/1994 | WO1994024164A2 Human monoclonal antibodies and processes and materials for making such antibodies |
| 10/27/1994 | WO1994024163A2 Bispecific antigen-binding molecules |
| 10/27/1994 | WO1994024160A2 Erythropoietin muteins with enhanced activity |
| 10/27/1994 | WO1994024159A1 Method and product for regulating cell responsiveness to external signals |
| 10/27/1994 | WO1994024158A1 Cellulose binding domain |
| 10/27/1994 | WO1994024156A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications |
| 10/27/1994 | WO1994024155A1 The therapeutic use of clostridium difficile toxin a |
| 10/27/1994 | WO1994024154A2 Immuno modulated peptide derivatives of leukokinin fragments |
| 10/27/1994 | WO1994024152A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 10/27/1994 | WO1994024151A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| 10/27/1994 | WO1994024150A3 Pepstatin derivatives for treatment, prevention and detection of infections |
| 10/27/1994 | WO1994024150A2 Pepstatin derivatives for treatment, prevention and detection of infections |
| 10/27/1994 | WO1994024149A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 10/27/1994 | WO1994024148A1 Modified protein and peptide pharmaceuticals |
| 10/27/1994 | WO1994024140A1 Hydroxamic acid derivatives |
| 10/27/1994 | WO1994023767A1 Oral drug delivery compositions and methods |
| 10/27/1994 | WO1994023758A1 Radiolabeled compounds for thrombus imaging |
| 10/27/1994 | WO1994023754A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 10/27/1994 | WO1994023747A1 Drug containing antibodies for treatment of t cell specific immune reactions and t cells leukemias |
| 10/27/1994 | WO1994023743A1 Method and compositions for digesting tissue |
| 10/27/1994 | WO1994023742A1 Methods and compositions for the prevention or treatment of sexually transmitted diseases |
| 10/27/1994 | WO1994023741A1 Enhancing the anti-tumor effect of melphalan with l-amino acid oxidase |
| 10/27/1994 | WO1994023740A1 Conjugates of growth factor and bone resorption inhibitor |
| 10/27/1994 | WO1994023739A1 METHOD OF DECREASING THE TOXICITY OF THERAPEUTIC COMPOSITIONS USING THYMOSIN β¿4? |
| 10/27/1994 | WO1994023738A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 10/27/1994 | WO1994023737A1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 10/27/1994 | WO1994023736A1 Method of treating depression using neurotrophins |
| 10/27/1994 | WO1994023735A1 Novel polypeptide having factor xa inhibitory activity |
| 10/27/1994 | WO1994023734A1 Method of treatment of diseases by deletion of t cells |
| 10/27/1994 | WO1994023733A1 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 10/27/1994 | WO1994023730A1 Method of treating hepatitis b infection |
| 10/27/1994 | WO1994023729A1 A process for separation of components from red blood cells |
| 10/27/1994 | WO1994023728A1 Immunogenic cancer proteins and peptides and method of use |
| 10/27/1994 | WO1994023709A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 10/27/1994 | WO1994023690A1 Method for removing nits from hair |
| 10/27/1994 | WO1994023582A1 Adenoviral vectors including dna encoding lung surfactant protein |
| 10/27/1994 | WO1994019465A3 Novel dna- binding regulator of c-myc expression which binds to the far upstream elements (fuse) and cdna therefor |
| 10/27/1994 | WO1994019463A3 Developmental tyrosine kinases and their ligands |
| 10/27/1994 | WO1994016068A3 Allergenic proteins and peptides from dog dander and uses therefor |
| 10/27/1994 | WO1994010313A3 Interferon tau compositions and methods of use |
| 10/27/1994 | CA2161143A1 New pharmaceutical preparations comprising cyclosporin for oral administration |
| 10/27/1994 | CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo |
| 10/27/1994 | CA2161089A1 Isolation, selection and propagation of animal transgenic stem cells |
| 10/27/1994 | CA2160983A1 Immunonanoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
| 10/27/1994 | CA2160878A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 10/27/1994 | CA2160713A1 Immunogenic cancer proteins and peptides and method of use |
| 10/27/1994 | CA2160670A1 Cellulose binding domain |
| 10/27/1994 | CA2160548A1 Method and product for regulating cell responsiveness to external signals |
| 10/27/1994 | CA2160537A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical prophylactic and diagnostic applications |
| 10/27/1994 | CA2160532A1 Method and compositions for digesting tissue |
| 10/27/1994 | CA2160224A1 Bispecific antigen-binding molecules |
| 10/27/1994 | CA2160157A1 A process for separation of components from red blood cells |
| 10/27/1994 | CA2160155A1 Model for gonococcal infection |
| 10/27/1994 | CA2160136A1 Adenoviral vectors including dna encoding lung surfactant protein |
| 10/27/1994 | CA2160120A1 Radiolabeled compounds for thrombus imaging |
| 10/27/1994 | CA2159891A1 Method of treatment of diseases by deletion of t cells |
| 10/27/1994 | CA2159738A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 10/27/1994 | CA2159218A1 Novel polypeptide having factor xa inhibitory activity |
| 10/27/1994 | CA2158972A1 1,5-benzodiazepine derivatives having cck and/or gastrin antogonistic activity |
| 10/27/1994 | CA2158582A1 Method for removing nits from hair |
| 10/27/1994 | CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations |
| 10/26/1994 | EP0621341A2 Monoclonal antibodies to bovine cytokines |
| 10/26/1994 | EP0621340A1 Product and process for the production and purification of recombinant polypeptides |
| 10/26/1994 | EP0621339A2 Immunogenic human influenza A virus haemagglutinin polypeptides |
| 10/26/1994 | EP0621338A2 Immunosuppressant able to block the interleukin - 2 response |
| 10/26/1994 | EP0621285A1 Novel megakaryocyte amplifier |
| 10/26/1994 | EP0621039A1 Keyhole limpet hemocyanin composition with enhanced anti-tumor activity against bladder cancer |
| 10/26/1994 | EP0620854A1 Expression and purification of recombinant soluble tissue factor |
| 10/26/1994 | EP0620850A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 10/26/1994 | EP0620826A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 10/26/1994 | EP0620825A1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 10/26/1994 | EP0620824A1 Peptides with tachykinin antagonist activity |
| 10/26/1994 | EP0620742A1 Inactivation of cytotoxic drugs |
| 10/26/1994 | EP0620741A1 Cytotoxic drug therapy |